4.4 Article

Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout

期刊

ARTHRITIS CARE & RESEARCH
卷 67, 期 9, 页码 1304-1315

出版社

WILEY
DOI: 10.1002/acr.22585

关键词

-

资金

  1. American College of Rheumatology, European League Against Rheumatism, Arthritis New Zealand
  2. Association Rhumatisme et Travail
  3. Asociacion de Reumatologos del Hospital de Cruces
  4. Pfizer
  5. AstraZeneca
  6. AbbVie
  7. Roche
  8. Ardea
  9. Bristol-Myers Squib
  10. Menarini
  11. Takeda
  12. Savient
  13. Teijin
  14. Fonterra
  15. Novartis
  16. Regeneron
  17. Metabolex
  18. Sobi
  19. Berlin Chemie Menarini
  20. Janssen Cilag

向作者/读者索取更多资源

ObjectiveTo determine which clinical, laboratory, and imaging features most accurately distinguished gout from non-gout. MethodsWe performed a cross-sectional study of consecutive rheumatology clinic patients with 1 swollen joint or subcutaneous tophus. Gout was defined by synovial fluid or tophus aspirate microscopy by certified examiners in all patients. The sample was randomly divided into a model development (two-thirds) and test sample (one-third). Univariate and multivariate association between clinical features and monosodium urate-defined gout was determined using logistic regression modeling. Shrinkage of regression weights was performed to prevent overfitting of the final model. Latent class analysis was conducted to identify patterns of joint involvement. ResultsIn total, 983 patients were included. Gout was present in 509 (52%). In the development sample (n=653), the following features were selected for the final model: joint erythema (multivariate odds ratio [OR] 2.13), difficulty walking (multivariate OR 7.34), time to maximal pain <24 hours (multivariate OR 1.32), resolution by 2 weeks (multivariate OR 3.58), tophus (multivariate OR 7.29), first metatarsophalangeal (MTP1) joint ever involved (multivariate OR 2.30), location of currently tender joints in other foot/ankle (multivariate OR 2.28) or MTP1 joint (multivariate OR 2.82), serum urate level >6 mg/dl (0.36 mmoles/liter; multivariate OR 3.35), ultrasound double contour sign (multivariate OR 7.23), and radiograph erosion or cyst (multivariate OR 2.49). The final model performed adequately in the test set, with no evidence of misfit, high discrimination, and predictive ability. MTP1 joint involvement was the most common joint pattern (39.4%) in gout cases. ConclusionTen key discriminating features have been identified for further evaluation for new gout classification criteria. Ultrasound findings and degree of uricemia add discriminating value, and will significantly contribute to more accurate classification criteria.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据